|
Volumn 39, Issue 3-4, 2005, Pages 517-522
|
Development and validation of a reversed-phase HPLC method for the determination of ezetimibe in pharmaceutical dosage forms
|
Author keywords
Ezetimibe; Hypercholesterolemia; Reversed phase HPLC; Tablets
|
Indexed keywords
EZETIMIBE;
ANALYTIC METHOD;
ANALYTICAL EQUIPMENT;
ARTICLE;
DRUG DETERMINATION;
ELUTION;
PRIORITY JOURNAL;
REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
TABLET;
VALIDATION PROCESS;
ACETONITRILES;
ANTICHOLESTEREMIC AGENTS;
AZETIDINES;
CALIBRATION;
CHEMISTRY, PHARMACEUTICAL;
CHROMATOGRAPHY, HIGH PRESSURE LIQUID;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG INDUSTRY;
DRUG STABILITY;
ENTEROCYTES;
HEPTANES;
HYDROGEN-ION CONCENTRATION;
HYPERCHOLESTEROLEMIA;
MODELS, CHEMICAL;
PHARMACEUTICAL PREPARATIONS;
REPRODUCIBILITY OF RESULTS;
SENSITIVITY AND SPECIFICITY;
SPECTROPHOTOMETRY, ULTRAVIOLET;
SULFONIC ACIDS;
TABLETS;
TEMPERATURE;
TIME FACTORS;
ULTRAVIOLET RAYS;
|
EID: 23944443039
PISSN: 07317085
EISSN: None
Source Type: Journal
DOI: 10.1016/j.jpba.2005.04.026 Document Type: Article |
Times cited : (164)
|
References (17)
|